| BERA | brainstem evoked response audiometry |
|---|---|
| BSER | brain stem evoked response [audiometry] |
| CORA | conditioned orientation reflex audiometry |
| EDA | electrodermal activity; electrodermal audiometry; electrolyte-deficient agar; electron donor accepto... |
| EEA | electroencephalic audiometry; end-to-end anastomosis |
| cancer, colon: screening and surveillance | Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer. (12 Dec 1998) |
|---|---|
| genetic screening | The process of testing individuals to find out if they carry genes for certain known genetic diseases, such as sickle cell anaemia. (09 Oct 1997) |
| carrier screening | Indiscriminate examination of members of a population to detect heterozygotes for serious disorders and counsel about the risks of marriages with other carriers, and by antenatal diagnosis where a married couple are both carriers; often sacrifices precision to simplicity and is most effectively applied to populations known to be at high risk. (05 Mar 2000) |
| mass screening | Organised periodic procedures performed on large groups of people for the purpose of detecting disease. (12 Dec 1998) |
| vision screening | Application of tests and examinations to identify visual defects or vision disorders occurring in specific populations, as in school children, the elderly, etc. It is differentiated from vision tests, which are given to evaluate/measure individual visual performance not related to a specific population. (12 Dec 1998) |
| multiphasic screening | The simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people. (12 Dec 1998) |
| prenatal screening | Screening for the detection of foetal disease, usually by ultrasound examination or by testing amniotic fluid obtained by amniocentesis. Other screening techniques include testing maternal serum and placental biopsy. (05 Mar 2000) |
| cytologic screening | A screening for the detection of early disease, usually cancer, through microscopic examination of a cellular specimen by inspecting each cell and structure present, usually at ×100 magnification with a mechanical stage, so that all areas are screened; the findings are evaluated and significant abnormalities are flagged (e.g., by dotting the cover slip) for further evaluation by a cytopathologist. This screening is usually performed by a cytotechnologist, but at times is done by automated machine prescreening. (05 Mar 2000) |
| screening | Examination of people with no symptoms, to detect unsuspected disease. (16 Dec 1997) |
| screening test | Any testing procedure designed to separate people or objects according to a fixed characteristic or property. (05 Mar 2000) |
| neonatal screening | The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic. (12 Dec 1998) |
| newborn screening | Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism. (12 Dec 1998) |
| Denver Developmental Screening Test | A scale used by psychologists and paediatricians to assess the developmental, intellectual, motor, and social maturity of children at any age level from birth to adolescence. (05 Mar 2000) |
| differential screening | Process in development of a multicellular organism by which cells become specialised for particular functions. Requires that there is selective expression of portions of the genome, the fully differentiated state may be preceded by a stage in which the cell is already programmed for differentiation but is not yet expressing the characteristic phenotype determination. (18 Nov 1997) |
| drug screening | Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. (12 Dec 1998) |